Partner Fund Management »

Sanofi-Aventis SA shares owned by Partner Fund Management

Quarter-by-quarter ownership of Sanofi-Aventis SA (SNY) shares owned by Partner Fund Management from 13F filings

Historical chart of Partner Fund Management investment in Sanofi-Aventis SA

Tip: Access up to 7 years of quarterly data

All positions including Sanofi-Aventis SA held by Partner Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sanofi-Aventis SA by Partner Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $8.5M 176k 48.46

More positions owned by Partner Fund Management

Tenet Healthcare Corp Com New (THC)
Eli Lilly & Co. (LLY)
Axsome Therapeutics (AXSM)
Centene Corporation (CNC)
Penumbra (PEN)
Ascendis Pharma A/s Sponsored Adr (ASND)
United Therapeutics Corporation (UTHR)
Bridgebio Pharma (BBIO)
Adma Biologics (ADMA)
Neurocrine Biosciences (NBIX)
Glaukos (GKOS)
Thermo Fisher Scientific (TMO)
Edwards Lifesciences (EW)
Icon SHS (ICLR)
Inhibrx Biosciences (INBX)

View all positions for Partner Fund Management

Top funds holding Sanofi-Aventis SA

Dodge & Cox
Fisher Investments
Barrow, Hanley, Mewhinney & Strauss
Invesco
BlackRock
Franklin Resources
Mondrian Investment Partners
Federated Investors
Robeco Investment Management
FMR
Raymond James Financial
Natixis Asset Management Advisors
Envestnet Asset Management
Wellington Management Company
Brandes Investment Partners

View all funds holding Sanofi-Aventis SA